abrdn Life Sciences Investors
HQL
83 hedge funds and large institutions have $142M invested in abrdn Life Sciences Investors in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 6 closing their positions.
150% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 6
74% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 19
11% more funds holding
Funds holding: 75 → 83 (+8)
0.09% less ownership
Funds ownership: 31.77% → 31.69% (-0.09%)
2% less capital inflows, than outflows
Capital inflows: $14.8M | Capital outflows: $15.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Shaker Financial Services
Arlington,
Virginia
|
+$2.28M |
| 2 |
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
|
+$1.6M |
| 3 |
Morgan Stanley
New York
|
+$1.43M |
| 4 |
World Investment Advisors
Santa Barbara,
California
|
+$1.27M |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$1.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Saba Capital Management
New York
|
-$5.9M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.09M |
| 3 |
Karpus Investment Management
Pittsford,
New York
|
-$1.79M |
| 4 |
1607 Capital Partners
Richmond,
Virginia
|
-$545K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$442K |
HQL Hedge Fund Activity: Q3 2025 in Review
83 of the 7,650 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2025, worth a combined $142M — up 21% from $118M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new HQL positions and 6 closed out — a net gain of 9 holders — while 33 added to existing stakes and 19 trimmed.
The largest buyer was Shaker Financial Services, adding an estimated $2.28M. The largest seller was Saba Capital Management, cutting an estimated $5.9M.
- 83 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2025, up from 75 in Q2 2025.
- Funds reported $142M of abrdn Life Sciences Investors stock for Q3 2025, up 21% quarter-over-quarter.
- 15 funds opened new abrdn Life Sciences Investors positions in Q3 2025 and 6 closed out, a net change of +9 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2025 was Shaker Financial Services, an estimated $2.28M added.
- The largest abrdn Life Sciences Investors seller in Q3 2025 was Saba Capital Management, an estimated $5.9M sold.
Based on aggregated 13F filings for Q3 2025.